Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02569801
Title A Study of GDC-0810 Versus Fulvestrant in Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy
Acronym HydranGea
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Genentech, Inc.
Age Groups: adult
Covered Countries USA | GBR | ESP | DEU | AUS

No variant requirements are available.